Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Fycompa

    - PMLiVE

    Novo Nordisk agrees to lower certain drug prices in the US

    The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid

    - PMLiVE

    Lilly announces agreement with US government to lower patient costs

    The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels

    - PMLiVE

    What is willingness to pay? – Comparing price testing methodologies

    Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to...

    Petauri Evidence

    - PMLiVE

    Ten participating drugmakers invited for further US Medicare drug price negotiations

    ASPE revealed that the IRA is expected to save around 857,000 US women $1,000 or more in 2025

    - PMLiVE

    Drugmakers submit counteroffers to US Medicare pricing negotiations

    New negotiated prices are set to be announced by 1 September 2024 and implemented in 2026

    Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

    Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

    Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...

    Petauri Evidence

    - PMLiVE

    Pfizer, Sanofi and others set to increase US drug prices in 2021

    Pressure from COVID-19 restrictions leads to drug price increases

    - PMLiVE

    Moderna looks to price COVID-19 vaccine at $50-$60 per course

    Shines spotlight on pricing strategies for potential vaccines

    - PMLiVE

    Germany’s coronavirus infections climb but deaths remain low

    Experts debate ‘anomaly’ as other countries record higher death rates

    - PMLiVE

    Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price

    Vowed to break patent if company goes ahead with proposed price

    - PMLiVE

    Biologic patent exclusivity scrapped in new US trade deal

    Drugmakers dealt a blow in latest trade negotiations

    - PMLiVE

    NHS leader warns politicians not to ‘weaponise’ the health service

    Top exec challenges main parties to provide credible solutions to big issues

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links